From pricing and demand to regulation and risk, inside the business of psychedelic retreats catering to business leaders.
The Drug Enforcement Administration (DEA) has finalized quotas for legal production of controlled substances in 2026—further ...
GH Research's stock rallied after saying the FDA lifted a hold on its experimental depression treatment The FDA lifted its hold on GH Research's psychedelic drug, sending the company's shares soaring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback